Clinical and Laboratory Haemostasis
Annual Scientific Meeting
4th & 5th June 2014
Conference Centre, The Atrium, Sheffield Hallam University

Delegates to our Annual Meeting are welcome to see again the presentations. Please click on the links in the programme below when available, supplying the username and password you were given at the meeting. When you have finished, click here to log out and return to the main page.

The presentations run as a 'flash' movie, and if you don't already have the flash player installed you should be given the opportunity to install it. After a 3 second delay, you can click your mouse on the slide to move on, let it run automatically (the slides change every 5 seconds), or use the navigation buttons at the bottom of the show.  After viewing a presentation, use the 'Back' button on your browser to return to this page.

The abstracts are available to all, no password is required.

Delegate Questionnaire - click here to see a summary of the responses to the Delegate Questionnaire

UK NEQAS for Blood Coagulation Point-of-Care
Dianne Kitchen, UK NEQAS for Blood Coagulation, Sheffield, UK

Abstract Presentation  

10.45-11.15 New oral anticoagulants: Pros and cons – efficacy and safety compared to vitamin K antagonists
Trevor Baglin, Addenbrooke’s Hospital, Cambridge, UK

Abstract Presentation  

Stroke prevention in atrial fibrillation
Matthew Fay, Westcliffe Medical Centre, Bradford, UK

Abstract Presentation  

The new oral anticoagulants in clinical use
Sue Rhodes, Great Western Hospital, Swindon, Wiltshire, UK

Abstract Presentation  

Update on the reversal of the oral direct inhibitor anticoagulants
Mike Makris, Sheffield Haemophilia & Thrombosis Centre, Sheffield, UK

Abstract Presentation  

Bruising in children
Alison Kemp, Cardiff University School of Medicine, Cardiff, UK

Abstract Presentation  

Anticoagulating children
Liz Chalmers, Royal Hospital for Sick Children, Glasgow, UK

Abstract Presentation  

Can plasma levels of Protein C, Protein S or Antithrombin predict an underlying genetic defect?
Anna Pavlova, University of Bonn, Germany

Abstract Presentation  

Risk factors for venous thromboembolism
Frits Rosendaal, Leiden University Medical Centre, Leiden, The Netherlands

Abstract Presentation  

Microparticle detection: Why and how?
Paul Harrison, University of Birmingham Medical School, Birmingham, UK

Abstract Presentation  

The GAPP approach to platelet function testing
Gillian Lowe, University of Birmingham, Birmingham, UK

Abstract Presentation  

ADAMTS 13 and the pathogenesis of thrombotic thrombocytopenic purpura
Bernhard Lämmle, University Hospital and University of Bern, Switzerland

Abstract Presentation  

Clinical and laboratory vignettes
David Perry, Addenbrooke’s Hospital, Cambridge, UK
Mrs Caroline Baglin, Addenbrooke’s Hospital, Cambridge, UK
Dr Myles Bradbury, Addenbrooke’s Hospital, Cambridge, UK

Abstract Presentation  

UK NEQAS for Blood Coagulation survey planning, preparation and performance analysis
Ian Jennings, UK NEQAS for Blood Coagulation, Sheffield, UK

Abstract Presentation  

How pre and post-analytical variables influence the clinical usefulness of tests and their results
Ann-Helen Kristoffersen, Haukeland University Hospital, Norway

Abstract Presentation  

Method validation and verification and a clotter’s guide to ISO15189(2012)
Kieron Hickey, Royal Hallamshire Hospital, Sheffield, UK

Abstract Presentation  

New developments in VWD diagnosis and treatment
Imre Bodo, St István and St László Hospital, Budapest, Hungary

Abstract Presentation  

The future of coagulation factor replacement
Flora Peyvandi, IRCCS Maggiore Hospital Foundation, Milan, Italy

Abstract Presentation  

UK NEQAS surveys with oral direct inhibitors/new oral anticoagulants
Steve Kitchen, UK NEQAS for Blood Coagulation, Sheffield, UK

Abstract Presentation  

UK NEQAS for Blood Coagulation VWF survey results and discrepancies
Ian Jennings, UK NEQAS for Blood Coagulation, Sheffield, UK

Abstract Presentation